Una vulnerabilidad en algunos tipos de células de cáncer de mama abre una vía para nuevos tratamientos

by Revista Genética Médica

Investigadores de la Universidad de Oxford y la Universidad Johns Hopkins han identificado una vulnerabilidad presente en un 9% de los cánceres de mama que podría ser explotada para eliminar de form...

Read more

Bioingenium to attend BioEurope 2020

by Bioingenium

Bioingenium will attend on October 26 to 29 the new edition of BioEurope event. This time due to the pandemic situation the conference would take place digitally. Our business development team would b...

Read more

FreeOx acquires the patent for the drug Ox-01 in the US for ischaemic stroke

by CataloniaBio

FreeOx Biotech, a CataloniaBio & HealthTech member, has been granted a patent for its most advanced drug, Ox-01, by the United States Patent and Trademark Office (USPTO). The patent protects the use o...

Read more

Metoprolol: an old drug with unique cardioprotective properties

by Centro Nacional de Investigaciones Cardiovasculares - CNIC

CNIC scientists have defined the unique ability if metoprolol to protect the heart during a heart attack

Read more

Nitrosamines Risk Assessment – Deadlines & Updates

by Asphalion

In both 2018 and 2019 the presence of N-nitrosamines was found in sartans with a tetrazole ring but it was also detected in other API/medicinal products (e.g. in some batches of pioglitazone and ranit...

Read more

Test genéticos, estudios estratégicos en la lucha contra el cáncer de mama

by OncoDNA

El día 19 de octubre se celebra el Día Internacional contra el Cáncer de Mama, una cita que tiene como objetivo concienciar y sensibilizar a la población mundial sobre el alcance que tiene esta en...

Read more

ORYZON publishes paper in Journal of Clinical Oncology demonstrating relevance of iadademstat in leukemia

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announces the p...

Read more

American Hospital of Paris and OncoDNA Partner to Advance Breast Cancer Patients Management

by OncoDNA

American Hospital of Paris and OncoDNA announced a new joint initiative that is intended to advance the use of precision medicine in routine clinical practice for patients with metastatic breast cance...

Read more

Volasertib, a potential new treatment for rhabdomyosarcoma, receives Orphan Drug Designation from the U.S. FDA

by Oncoheroes Biosciences

Oncoheroe​s Biosciences, a biotech focused on advancing new therapies for childhood cancer, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation (ODD) to vo...

Read more

El CSIC se une a la infraestructura EU-OPENSCREEN para investigar en química biológica y nuevos fármacos

by CSIC - Centro Superior de Investigaciones Científicas

Esta red pone en común diversos centros de investigación europeos para buscar sustancias biológicamente activas, como nuevos fármacos para tratar la Covid-19

Read more

Seeking COVID-19 Therapeutic Candidates with a Computational Approach

by CAS, a division of the American Chemical Society

Since the World Health Organization declared COVID-19 a pandemic, researchers have learned a tremendous amount about SARS-CoV-2, the new coronavirus that causes this disease. However, despite extensiv...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palex and Duomed to create the first tru...

by Palex Medical

Palex Medical has announced the execution of a put option agreement fo...

Photos Stream